“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials,” an AstraZeneca spokesperson said. Source
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials,” an AstraZeneca spokesperson said. Source